In this edition:
– Intervention for improving acute HF outcomes
– Dapagliflozin in HFimpEF
– Empagliflozin in HFpEF vs. HF with midrange EF
– Intravenous ferric derisomaltose in iron-deficient HF
– Up-titration of guideline-directed medical therapies for acute HF
– Associations of all-cause mortality with statin therapy in HFpEF
– Empagliflozin improves outcomes in HFpEF irrespective of BP
– Combining loop with thiazide diuretics for decompensated HF
– Decongestion with acetazolamide in acute decompensated HF across LVEF spectrum
– Ambulatory haemodynamic-guided management reduces HF hospitalisations
Download Heart_Failure_Research_Review:_Issue_74(pdf) with commentary by Prof Andrew Coats

